(COO) The Cooper Companies - Ratings and Ratios

The Cooper Companies, Inc. (NASDAQ:COO) is a global medical device company specializing in two primary business segments: CooperVision and CooperSurgical. CooperVision is a leading manufacturer of contact lenses, offering a wide range of products to correct vision impairments such as astigmatism, presbyopia, and myopia. The segment also provides spherical lenses for nearsightedness and farsightedness, catering to diverse markets across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. CooperSurgical, on the other hand, focuses on womens and family healthcare, providing fertility solutions, contraceptive devices, and cryopreservation services. Key products include the Paragard intrauterine device, fertility consumables, and genomic services such as genetic testing. The company distributes its products to healthcare professionals, distributors, and organizations worldwide.

Ticker Symbol: COO, Exchange: NASDAQ, Type: Common Stock, Country Origin: United States, GICS Sub Industry: Health Care Supplies.

3-Month Forecast: Based on the technical and fundamental data, COO is expected to experience short-term volatility due to its high P/E ratio (35.64) and declining SMA trends (SMA 20: 79.17, SMA 50: 83.63, SMA 200: 95.15). The stock may face downward pressure in the near term as it trades below its 200-day moving average. However, its forward P/E of 18.48 and moderate ATR (2.84) suggest potential stabilization. Fundamentally, the companys market cap of $14.75 billion and P/S ratio of 3.73 indicate a stable financial position, but the relatively low RoE (5.11%) may weigh on investor sentiment. Overall, COO is likely to remain range-bound with a slight bearish bias in the short term.